Anika Therapeutics Q3 Adj. EPS $0.29 Beats $0.06 Estimate, Sales $30.594M Beat $29.436M Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.06 by 383.33 percent. This is a 625 percent increase over earnings of $0.04 per share from
Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.06 by 383.33 percent. This is a 625 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $30.594 million which beat the analyst consensus estimate of $29.436 million by 3.94 percent. This is a 10.05 percent increase over sales of $27.800 million the same period last year.